PMVP

PMV Pharmaceuticals (PMVP)

About PMV Pharmaceuticals (PMVP)

PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.

Details

Daily high
$1.53
Daily low
$1.45
Price at open
$1.48
52 Week High
$6.61
52 Week Low
$1.18
Market cap
78.8M
Dividend yield
0.00%
Volume
2
Avg. volume
195,949
P/E ratio
-1.58

PMV Pharmaceuticals News

Details

Daily high
$1.53
Daily low
$1.45
Price at open
$1.48
52 Week High
$6.61
52 Week Low
$1.18
Market cap
78.8M
Dividend yield
0.00%
Volume
2
Avg. volume
195,949
P/E ratio
-1.58